3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Prostatic Neoplasms
30
Lung Neoplasms
30
Carcinoma, Non-Small-Cell Lung
26
Leukemia, Myeloid, Acute
25
Multiple Myeloma
22
Breast Neoplasms
20
Lymphoma
18
Carcinoma, Renal Cell
17
Urinary Bladder Neoplasms
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Myelodysplastic Syndromes
14
Lymphoma, Large B-Cell, Diffuse
14
Colorectal Neoplasms
14
Pancreatic Neoplasms
11
Neoplasm Metastasis
11
Ovarian Neoplasms
10
Myeloproliferative Disorders
10
Mouth Neoplasms
10
Glioma
10
Glioblastoma
10
Burkitt Lymphoma
10
Squamous Cell Carcinoma of Head and Neck
9
Triple Negative Breast Neoplasms
8
Sarcoma
8
Rectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Melanoma
8
Lymphoma, Non-Hodgkin
8
Laryngeal Neoplasms
8
Carcinoma
8
Interventions
Vitamin D
2
Tirzepatide
2
Metformin
2
licogliflozin
1
indole-3-carbinol
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Tablets
1
Specimen Handling
1
Resistance Training
1
Progestins
1
Pregabalin
1
Orlistat
1
Organizational Objectives
1
Omeprazole
1
Observation
1
Naltrexone
1
Ketorolac
1
Exergaming
1
Exercise
1
Exenatide
1
Diet, Plant-Based
1
Dexmedetomidine
1
Dalteparin
1
Counseling
1
Cholecalciferol
1
Calcium Citrate
1
Calcium Carbonate
1
Calcitriol
1
CKD732
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Obesity
×
Specimen Handling
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled